ARID1A and colorectal carcinoma: A gene set enrichment analysis conducted by Tokunaga et al. showed that ARID1A mutant status was closely correlated to the DNA repair pathway, mediating chemotherapy/radiotherapy sensitivity of CRC (Tokunaga et al. 2020).